Article Contents ::
- 1 Details About Generic Salt :: Magnesiu
- 2 Main Medicine Class:: Laxative
- 3 (mag-NEE-zee-uhm SIH-trate) Citrate of Magnesia, Citro-Nesia, Citro-Mag Class: Laxative
- 4 Drugs Class ::
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Details About Generic Salt :: Magnesiu
Main Medicine Class:: Laxative
(mag-NEE-zee-uhm SIH-trate)
Citrate of Magnesia, Citro-Nesia, Citro-Mag
Class: Laxative
Drugs Class ::
Action Attracts and retains water in intestinal lumen, thereby increasing intraluminal pressure and inducing urge to defecate.
Indications for Drugs ::
Indications Short-term treatment of constipation; evacuation of colon for rectal and bowel evaluations.
Drug Dose ::
Route/Dosage
ADULTS: PO 1 glassful (approximately 240 ml) prn. CHILDREN 2–6 YR: PO 4–12 ml. CHILDREN 6–12 YR: PO 50–100 ml. Repeat if necessary.
Contraindication ::
Contraindications Hypersensitivity to any ingredient; nausea, vomiting or other symptoms of appendicitis; acute surgical abdomen; fecal impaction; intestinal obstruction; ndiagnosed abdominal pain; intestinal bleeding; renal disease.
Drug Precautions ::
Precautions
Pregnancy: Pregnancy category undetermined. Lactation: Undetermined. Children: Exercise caution; consult physician. One 6-week old infant developed magnesium poisoning after several doses for constipation. Abuse/dependency: Chronic use of laxatives may lead to laxative dependency, which may result in fluid and electrolyte imbalances, steatorrhea, osteomalacia and vitamin and mineral deficiencies. Fluid and electrolyte imbalance: Excessive laxative use may lead to significant fluid and electrolyte imbalance. Rectal bleeding or failure to respond: May indicate serious condition requiring further attention. Renal impairment: Avoid in patients with renal dysfunction. Hypermagnesemia and toxicity may occur due to decreased clearance of magnesium ion.
PATIENT CARE CONSIDERATIONS |
|
Drug Side Effects ::
Adverse Reactions
CV: Palpitations. CNS: Dizziness; fainting. GI: Excessive bowel activity (eg, cramping, diarrhea, nausea, vomiting); perianal irritation; bloating; flatulence; abdominal cramping. OTHER: Sweating; weakness; fluid and electrolyte imbalance.
Drug Mode of Action ::
Action Attracts and retains water in intestinal lumen, thereby increasing intraluminal pressure and inducing urge to defecate.
Drug Interactions ::
Interactions
Nitrofurantoin: Reduced anti-infective action. Penicillamine: Reduced action of penicillamine. Tetracyclines: Impaired absorption of tetracyclines.
Drug Assesment ::
Assessment/Interventions
- Obtain patient history, including drug history and any known allergies. Note symptoms of appendicitis, fecal impaction, renal disease or small bowel obstruction.
- Observe for distended abdomen and auscultate for presence of bowel sounds.
- Monitor for electrolyte imbalances and dehydration.
- If nausea, diarrhea, abdominal distention, increased abdominal pain or rectal bleeding occur, notify physician.
|
Drug Storage/Management ::
Administration/Storage
- Chilling medication or giving with ice may improve palatability.
- Administer on empty stomach and give with full glass of water to increase effectiveness of medication.
- Store in tightly closed container in cool dry place.
Drug Notes ::
Patient/Family Education
- Explain that drug should not be used routinely for constipation; ependence can result.
- Instruct patient to report any of these symptoms to physician: nrelieved constipation, vomiting, diarrhea, abdominal fullness, rectal bleeding, dizziness and muscle cramps.
- Review information on proper use and storage of medication.